RAP1 deficiency did not influence the proliferation or senescence of hNSCs. (A) Brightfield and immunofluorescence micrographs of WT and RAP1−/− hNSCs showed normal morphology and expression of the NSC markers PAX6, SOX2 and Nestin. Scale bar, 50 μm. (B) Immunofluorescence micrographs of RAP1 in ...
more
RAP1 deficiency did not influence the proliferation or senescence of hNSCs. (A) Brightfield and immunofluorescence micrographs of WT and RAP1−/− hNSCs showed normal morphology and expression of the NSC markers PAX6, SOX2 and Nestin. Scale bar, 50 μm. (B) Immunofluorescence micrographs of RAP1 in WT and RAP1−/− hNSCs. Scale bar, 10 μm. (C) Western blotting analysis demonstrated the absence of RAP1 in RAP1−/− hNSCs. β-Tubulin was used as a loading control. (D) Venn diagram showing differentially expressed genes in RAP1−/− vs. WT hMSCs and hNSCs. RELN was labeled by an arrow. (E) Biological process GO enrichment analysis of differentially expressed genes in RAP1−/− vs. WT hNSCs. The top 5 enriched biological process GO terms were shown. (F) Heatmap of differentially expressed genes in RAP1−/− vs. WT hNSCs. RELN was labeled by an arrow. (G) Volcano plot of differentially expressed genes in RAP1−/− vs. WT hNSCs. RELN was labeled by an arrow. (H) qRT-PCR analysis verified that RELN was downregulated in RAP1−/− hNSCs. Data were presented as the mean ± SEM, n = 3. ***P < 0.001. (I) ChIP-PCR of RAP1 enrichment at the RELN promoter region in WT and RAP1−/− hNSCs. Data were presented as the mean ± SEM, n = 3. **P < 0.01. (J) Methylation-specific PCR analysis of the RELN promoter in WT and RAP1−/− hNSCs demonstrated hypermethylation of the RELN promoter in RAP1−/− hNSCs. Data were presented as the mean ± SEM, n = 3. **P < 0.01. (K) ChIP-PCR analysis of RAP1 enrichment at the telomeres in WT and RAP1−/− hNSCs. Data were presented as the mean ± SEM, n = 3. ***P < 0.001. (L) Terminal restriction fragment analysis of WT and RAP1−/− hNSCs by Southern blotting demonstrated the elongated telomere length in RAP1−/− hNSCs. (M) Telomere length analysis of WT and RAP1−/− hNSCs by qPCR. Data were presented as the mean ± SEM, n = 3. ***P < 0.001. (N) Cell growth curves of WT and RAP1−/− hNSCs showed comparable proliferation ability of WT and RAP1−/− hNSCs. (O) Immunostaining of the proliferation marker Ki67 in WT and RAP1−/− hNSCs. Scale bar, 50 μm. Data were presented as the mean ± SEM, n = 6. NS, not significant. (P) Clonal expansion analysis of WT and RAP1−/− hNSCs. Data were presented as the mean ± SEM, n = 3. NS, not significant. (Q) SA-β-gal staining of WT and RAP1−/− hNSCs. Scale bar, 50 μm. Data were presented as the mean ± SEM, n = 6. NS, not significant
less